JoVE Logo

Oturum Aç

6.25 : Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral and intravenous administration.

  1. Class I: Drugs with high solubility and high permeability, resulting in efficient absorption and minimal transporter influence (e.g., metoprolol, propranolol, and amoxicillin).
  2. Class II: Drugs with low solubility but high permeability, where efflux transporters can significantly limit absorption and pump drugs into bile (e.g., ezetimibe, ibuprofen, and ketoconazole).
  3. Class III: Drugs with high solubility but low permeability, where uptake transporters may enhance absorption (e.g., cimetidine, cephalexin, and ranitidine).
  4. Class IV: Drugs with low solubility and permeability. They often exhibit poor bioavailability due to dual limitations (e.g., itraconazole, chlorothiazide, and furosemide).

By integrating solubility and permeability, the Biopharmaceutical Classification System highlights how transporters influence drug disposition; for instance, Class II drugs face significant challenges due to efflux into the gastrointestinal lumen and biliary excretion.

Etiketler

Hepatic Drug ClearanceTransportersIntrinsic ClearanceBiopharmaceutical Classification System BCSDrug DispositionSolubilityPermeabilityClass I DrugsClass II DrugsClass III DrugsClass IV DrugsAbsorptionEfflux TransportersUptake TransportersBioavailability

Bölümden 6:

article

Now Playing

6.25 : Hepatic Drug Clearance: Role of Transporters

Pharmacokinetics: Drug Excretion and Clearance

41 Görüntüleme Sayısı

article

6.1 : Drug Elimination: Overview

Pharmacokinetics: Drug Excretion and Clearance

1.1K Görüntüleme Sayısı

article

6.2 : Elimination Kinetics: First-Order and Zero-Order

Pharmacokinetics: Drug Excretion and Clearance

485 Görüntüleme Sayısı

article

6.3 : Renal Drug Excretion: Overview

Pharmacokinetics: Drug Excretion and Clearance

125 Görüntüleme Sayısı

article

6.4 : Renal Drug Excretion: Glomerular Filtration

Pharmacokinetics: Drug Excretion and Clearance

180 Görüntüleme Sayısı

article

6.5 : Renal Drug Excretion: Tubular Reabsorption

Pharmacokinetics: Drug Excretion and Clearance

115 Görüntüleme Sayısı

article

6.6 : Renal Drug Excretion: Tubular Secretion

Pharmacokinetics: Drug Excretion and Clearance

144 Görüntüleme Sayısı

article

6.7 : Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

Pharmacokinetics: Drug Excretion and Clearance

140 Görüntüleme Sayısı

article

6.8 : Hepatic Drug Excretion: Enterohepatic Cycling

Pharmacokinetics: Drug Excretion and Clearance

1.1K Görüntüleme Sayısı

article

6.9 : Hepatic Drug Excretion: Influencing Factors

Pharmacokinetics: Drug Excretion and Clearance

94 Görüntüleme Sayısı

article

6.10 : Drug Excretion: Pulmonary and Glandular Routes

Pharmacokinetics: Drug Excretion and Clearance

85 Görüntüleme Sayısı

article

6.11 : Drug Excretion: Miscellaneous Routes

Pharmacokinetics: Drug Excretion and Clearance

48 Görüntüleme Sayısı

article

6.12 : Drug Clearance: Overview

Pharmacokinetics: Drug Excretion and Clearance

57 Görüntüleme Sayısı

article

6.13 : Clearance Models: Physiological Models

Pharmacokinetics: Drug Excretion and Clearance

52 Görüntüleme Sayısı

article

6.14 : Clearance Models: Compartment Models

Pharmacokinetics: Drug Excretion and Clearance

53 Görüntüleme Sayısı

See More

JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır